Announcing new collaboration with Scope Research Institute of Electrophysiology in China

Public Announcement

Forging groundbreaking scientific collaboration with Scope Research Institute of Electrophysiology in China

Scope Research Institute of Electrophysiology (Scope), a leading contract research organization (CRO) founded by a team of experienced scientists passionate about ion channels, and Sophion Bioscience A/S (Sophion), a pioneering life science company specializing in automated patch clamp and cell line solutions, proudly announce the inauguration of their scientific collaboration agreement aimed at expanding Ion Channel research and the scientific validation of Automated Patch Clamp technology in China. This partnership signifies a significant milestone in the pursuit of scientific innovation and underscores a shared commitment to pushing the boundaries of scientific discovery in the field of electrophysiology.

Dr. Anissa Bara, Sophion Global Application Scientist, Mr. Kevin Zhang, Sophion China Country Manager, Mrs Yifan Huang, China Sales Executive, Dr. Lisa Jia, China Application Scientist, Dr. Guoliang Hao, Chairman of SCOPE, Mr. Ray Guo, General Manager of SCOPE, Dr. Gongxin Wang, Director of SCOPE, Ms. Xiuming Dong, Marketing Head of SCOPE attended the opening ceremony.

The key parts of the collaboration include:

  1. Expanding Scientific Validation: The collaboration will focus on expanding the scientific validation of Automated Patch Clamp technology in China, leveraging the expertise and resources of both organizations to conduct rigorous experimentation and research.
  2. Providing Laboratory Facilities for Training and Demonstrations: SCOPE, situated in the historically rich city of Kaifeng, China, boasts a state-of-the-art laboratory spanning 1300 m². Equipped with cutting-edge technologies such as patch clamp rigs, multi-electrode systems, and Langendorff & working heart systems, Scope offers comprehensive cardiac and neuronal ion channel screening services, preclinical cardiac safety assessments, and drug discovery assays. The institute will provide laboratory facilities for training and demonstration purposes for electrophysiologists in China, fostering greater understanding and proficiency among researchers.
  3. Collaboration on Seminars and Training Sessions: The agreement includes collaboration on seminars and training sessions for electrophysiologists in China, where the QPatch Compact system will be integrated into the program. These sessions will be conducted jointly by experts from both SCOPE and Sophion, enhancing the educational experience and knowledge dissemination.
  4. Joint Scientific Research: Both parties will work together on generating further scientific research into electrophysiology in China, with a focus on advancing understanding and exploring new avenues of research.

"This agreement is an important step in the expansion and investment of Sophion into the Chinese market for electrophysiology and Automated Patch Clamp systems. With this agreement, Sophion will be able to provide even better support to existing customers and stakeholders."

— Kevin Zhang, Sophion Country Manager at Sophion Bioscience (Shanghai) Co., Ltd.

This collaboration between SCOPE and Sophion represents a significant step forward in the field of electrophysiology research in China. By leveraging their respective expertise and resources, both organizations are poised to make meaningful contributions to scientific knowledge and advance the understanding of complex biological processes.

For media inquiries or further information, please contact:

Kevin Zhang
Sophion Bioscience (Shanghai) Co., Ltd.
+86 21 68060612

Contact us